Optimization of intermittent dosing strategies of KRAS G12C inhibitors in preclinical lung cancer model

被引：0
|
作者：
Navarro, Valeria Estrada
Panneton, Vincent
Dong, Lauren
Choi, Hyejin
Venkatesh, Divya
Maniyar, Rachana
Schulze, Isabell
Wolchok, Jedd D.
Merghoub, Taha
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7274
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7274
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Overcoming resistance to KRAS G12C inhibitors in lung cancer
    Ambrogio, Chiara
    CANCER SCIENCE, 2023, 114 : 987 - 987
  • [2] Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
    Cucurull, Marc
    Notario, Lucia
    Sanchez-Cespedes, Montse
    Hierro, Cinta
    Estival, Anna
    Carcereny, Enric
    Saigi, Maria
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [3] Using the ResCu system for preclinical testing of KRAS G12C inhibitors
    Ruiz, Victor M.
    Hill, Lindsay
    Gadde, Manasa
    Bulow, Christopher
    Morri, Maurizio
    Goldner, Nicholas
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [4] KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer
    Xiao, Annie
    Fakih, Marwan
    CLINICAL COLORECTAL CANCER, 2024, 23 (03) : 199 - 206
  • [5] Resistance looms for KRAS G12C inhibitors and rational tackling strategies
    Zhang, Junmin
    Zhang, Juanhong
    Liu, Qing
    Fan, Xing-Xing
    Leung, Elaine Lai-Han
    Yao, Xiao-Jun
    Liu, Liang
    PHARMACOLOGY & THERAPEUTICS, 2022, 229
  • [6] Oncogenic non-G12C KRAS mutations in KRAS G12C mutated lung adenocarcinomas in TRACERx and GENIE: A reservoir for intrinsic resistance to KRAS G12C inhibitors
    Marinelli, D.
    Pisegna, S.
    Giammaruco, M.
    Chesi, P.
    Mammone, G.
    Ceddia, S.
    Gazzaniga, P.
    Cortesi, E.
    Gelibter, A. J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1345 - S1346
  • [7] Targeting KRAS G12C with Covalent Inhibitors
    Ostrem, Jonathan M. L.
    Shokat, Kevan M.
    ANNUAL REVIEW OF CANCER BIOLOGY, 2022, 6 : 49 - 64
  • [8] Mechanisms of Resistance to KRAS G12C Inhibitors
    Ambrogio, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S96 - S96
  • [9] Clinical Data for KRAS G12C Inhibitors
    Kim, H. R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S95 - S96
  • [10] The promise and peril of KRAS G12C inhibitors
    Moore, Amanda R.
    Malek, Shiva
    CANCER CELL, 2021, 39 (08) : 1059 - 1061
12345